Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Antibiotic Selection00:57

Antibiotic Selection

61.8K
Overview
61.8K
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

7.1K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
7.1K
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

1.8K
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.8K
Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration01:23

Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration

70
Drug elimination from the body primarily occurs through metabolic and excretion pathways. Hepatic metabolism transforms lipophilic drugs into hydrophilic forms for excretion, typically via enzymatic processes classified as phase I (modification) and phase II (conjugation). Renal excretion eliminates drugs and metabolites through filtration and secretion in the kidneys. Impairment in liver or kidney function can hinder these processes, delaying drug clearance and extending the drug’s...
70
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

520
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
520
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

1.8K
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
1.8K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

A natural depsipeptide antibiotic binds the E-site of the bacterial ribosome.

Nature·2026
Same author

The role of whole genome sequencing in antimicrobial susceptibility prediction of bacteria: 2025 update from the European Committee on Antimicrobial Susceptibility Testing Subcommittee.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2026
Same author

Ngt-1: A glycosyltransferase that confers resistance to three distinct antibiotic classes.

The Journal of biological chemistry·2026
Same author

A yeast synthetic biotic platform for delivery of therapeutic nanobodies to ameliorate gastrointestinal inflammation.

Disease models & mechanisms·2026
Same author

Directed evolution of the pathogenic mold <i>Aspergillus fumigatus</i> reveals novel genes contributing to triazole resistance.

Antimicrobial agents and chemotherapy·2026
Same author

An Acetyltransferase Conferring Self-Resistance of the Producer to Lasso Peptide Antibiotic Lariocidin.

ACS infectious diseases·2026

関連する実験動画

Updated: Mar 14, 2026

Antibiotic Dereplication Using the Antibiotic Resistance Platform
10:49

Antibiotic Dereplication Using the Antibiotic Resistance Platform

Published on: October 17, 2019

11.8K

古い 抗生物質 の 効能 を 強化 する

Gerard D Wright1

  • 1Michael G. DeGroote Institute for Infectious Disease Research, McMaster University, Hamilton, ON L8S 4L8, Canada.

Cell
|October 8, 2016
PubMed
まとめ

アビバクタムとセフタジドームを組み合わせたアビカズは 細菌感染と闘います アビバクタムはセフタジドームを細菌の酵素から保護し,薬剤耐性を克服します.

科学分野:

  • 微生物学
  • 薬理学について
  • 感染症

背景:

  • バクテリア感染は 世界的な健康上の脅威です
  • 抗生物質耐性 特にβ-ラクタマース酵素による抗生物質耐性は 増大する課題です
  • セフタジジムは,多くのグラム陰性細菌に対して有効なセファロスポリン抗生物質です.

研究 の 目的:

  • アビカズ (セフタジドーム- アビバクタム) の作用機構について説明します.
  • アビバクタムがβ- ラクトマース媒介の抵抗を克服する方法を説明する.
  • ペニシリン結合タンパク質 (PBP) が抗生物質の有効性に関与することを強調する.

主な方法:

  • この研究は,Avycazの成分と細菌の標的間の生化学的相互作用に焦点を当てています.
  • アビバクタムによるβ- ラクタマース酵素の抑制を詳細に説明しています.
  • 細菌の細胞壁合成に不可欠なPBPへのセフタジジムの結合を記述しています.

主要な成果:

  • 細菌の細胞壁合成をPBPで標的とするセフタジドームとアビバクタムを組み合わせた薬です.
  • アビバクタムはβ- ラクタマース阻害剤として作用し,セフタジジムの不活性化を防ぐ.

さらに関連する動画

Visualization of Bacterial Resistance using Fluorescent Antibiotic Probes
08:23

Visualization of Bacterial Resistance using Fluorescent Antibiotic Probes

Published on: March 2, 2020

13.7K
Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
11:15

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Published on: July 24, 2021

5.6K

関連する実験動画

Last Updated: Mar 14, 2026

Antibiotic Dereplication Using the Antibiotic Resistance Platform
10:49

Antibiotic Dereplication Using the Antibiotic Resistance Platform

Published on: October 17, 2019

11.8K
Visualization of Bacterial Resistance using Fluorescent Antibiotic Probes
08:23

Visualization of Bacterial Resistance using Fluorescent Antibiotic Probes

Published on: March 2, 2020

13.7K
Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
11:15

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Published on: July 24, 2021

5.6K
  • この組み合わせは,β- ラクタマスを生成する細菌に対するセフタジジムの有効性を回復させます.
  • 結論:

    • アビカズは,耐性細菌感染症に対する新しい治療法です.
    • この組み合わせは,β- ラクタマゼによって介在する細菌の抵抗メカニズムを効果的に中和する.
    • このアプローチはセフタジジムのような 既知の抗生物質の有効性を高めます